EMZOLAM
Main information
- Trade name:
- EMZOLAM 5 CAP
- Active ingredient:
- TEMOZOLOMIDE
- Available from:
- MIRACALUS
- Dosage:
- 20MG
- Pharmaceutical form:
- CAP
- Composition:
- 5
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
13-7-2018
Human medicines European public assessment report (EPAR): Temomedac, temozolomide, Revision: 11, Authorised
Europe - EMA - European Medicines Agency
11-7-2018
Human medicines European public assessment report (EPAR): Temozolomide Sun, temozolomide, Revision: 11, Authorised
Europe - EMA - European Medicines Agency
10-7-2018
Human medicines European public assessment report (EPAR): Temozolomide Hexal, temozolomide, Revision: 14, Authorised
Europe - EMA - European Medicines Agency
21-6-2018
Human medicines European public assessment report (EPAR): Temozolomide Accord, temozolomide, Revision: 16, Authorised
Europe - EMA - European Medicines Agency
12-6-2018
Human medicines European public assessment report (EPAR): Temozolomide Teva, temozolomide, Revision: 17, Authorised
Europe - EMA - European Medicines Agency
12-6-2018
Human medicines European public assessment report (EPAR): Temodal, temozolomide, Revision: 30, Authorised
Europe - EMA - European Medicines Agency
10-7-2018
Temozolomide HEXAL (Hexal AG)
Temozolomide HEXAL (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2018) 4481 of Tue, 10 Jul 2018
Europe -DG Health and Food Safety
10-7-2018
Temozolomide Sandoz (Sandoz GmbH)
Temozolomide Sandoz (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2018)4480 of Tue, 10 Jul 2018
Europe -DG Health and Food Safety
3-7-2018
Temozolomide Accord (Accord Healthcare Limited)
Temozolomide Accord (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2018) 4240 of Tue, 03 Jul 2018
Europe -DG Health and Food Safety
30-5-2018
Temodal (Merck Sharp and Dohme Limited)
Temodal (Active substance: temozolomide) - PSUSA - Modification - Commission Decision (2018)3466 of Wed, 30 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/229/PSUSA/2886/201707
Europe -DG Health and Food Safety